Advanced Solid Tumors or Lymphomas
| Status: | Archived |
|---|---|
| Conditions: | Cancer, Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2011 |
A Phase I Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas
The purpose of this study is to determine the MTD and/or RP2D of ABI-011 when administered
by IV on Day 1, Day 8 and Day 15 with one week of rest for patients with advanced solid
tumor malignancies and lymphomas.
Dose limiting toxicities (DLT), maximum tolerated dose (MTD)
We found this trial at
2
sites
4201 St Antoine St
Detroit, Michigan 48201
Detroit, Michigan 48201
(313) 577-1429
Wayne State University/Detroit Medical Center Founded in 1868, the Wayne State University School of Medicine...
Click here to add this to my saved trials
Click here to add this to my saved trials